TY - JOUR A1 - Rödel, Claudia Jasmin A1 - Abdelilah-Seyfried, Salim T1 - A zebrafish toolbox for biomechanical signaling in cardiovascular development and disease JF - Current opinion in hematology N2 - Purpose of review The zebrafish embryo has emerged as a powerful model organism to investigate the mechanisms by which biophysical forces regulate vascular and cardiac cell biology during development and disease. A versatile arsenal of methods and tools is available to manipulate and analyze biomechanical signaling. This review aims to provide an overview of the experimental strategies and tools that have been utilized to study biomechanical signaling in cardiovascular developmental processes and different vascular disease models in the zebrafish embryo. Within the scope of this review, we focus on work published during the last two years. Recent findings Genetic and pharmacological tools for the manipulation of cardiac function allow alterations of hemodynamic flow patterns in the zebrafish embryo and various types of transgenic lines are available to report endothelial cell responses to biophysical forces. These tools have not only revealed the impact of biophysical forces on cardiovascular development but also helped to establish more accurate models for cardiovascular diseases including cerebral cavernous malformations, hereditary hemorrhagic telangiectasias, arteriovenous malformations, and lymphangiopathies. Summary The zebrafish embryo is a valuable vertebrate model in which in-vivo manipulations of biophysical forces due to cardiac contractility and blood flow can be performed. These analyses give important insights into biomechanical signaling pathways that control endothelial and endocardial cell behaviors. The technical advances using this vertebrate model will advance our understanding of the impact of biophysical forces in cardiovascular pathologies. KW - angiogenesis KW - cardiovascular system KW - Danio rerio (zebrafish) KW - genetic KW - tools KW - mechanobiology Y1 - 2021 U6 - https://doi.org/10.1097/MOH.0000000000000648 SN - 1065-6251 SN - 1531-7048 VL - 28 IS - 3 SP - 198 EP - 207 PB - Lippincott Williams & Wilkins CY - Philadelphia ER -